{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T02:50:13Z","timestamp":1684205413339},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,1,18]],"date-time":"2011-01-18T00:00:00Z","timestamp":1295308800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1007\/s00296-010-1786-6","type":"journal-article","created":{"date-parts":[[2011,1,17]],"date-time":"2011-01-17T08:26:38Z","timestamp":1295252798000},"page":"273-275","source":"Crossref","is-referenced-by-count":4,"title":["Leflunomide use in a cytomegalovirus infection of a patient with dermatomyositis"],"prefix":"10.1007","volume":"32","author":[{"given":"Alberto O.","family":"Orden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan C.","family":"Chuluyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana C.","family":"Colombini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rub\u00e9n F.","family":"Barbera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,1,18]]},"reference":[{"issue":"6","key":"1786_CR1","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2340\/00015555-0152","volume":"86","author":"A Hashimoto","year":"2006","unstructured":"Hashimoto A, Okuyama R, Watanabe H, Tagami H, Aiba S (2006) Cytomegalovirus infection complicating immunosuppressive therapy for dermatomyositis. Acta Derm Venereol 86(6):535\u2013537","journal-title":"Acta Derm Venereol"},{"issue":"9","key":"1786_CR2","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1093\/rheumatology\/ken231","volume":"47","author":"Y Takizawa","year":"2008","unstructured":"Takizawa Y, Inokuma S, Tanaka Y, Saito K, Atsumi T, Hirakata M, Kameda H, Hirohata S, Kondo H, Kumagai S, Tanaka Y (2008) Clinical characteristics of cytomegalovirus infection in rheumatic diseases: multicentre survey in a large patient population. Rheumatology (Oxford) 47(9):1373\u20131378","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"1786_CR3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2174\/157489107779561634","volume":"2","author":"C Steininger","year":"2007","unstructured":"Steininger C (2007) Novel therapies for cytomegalovirus disease. Recent Patents Anti-Infect Drug Disc 2(1):53\u201372","journal-title":"Recent Patents Anti-Infect Drug Disc"},{"issue":"5\u20136","key":"1786_CR4","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1159\/000053979","volume":"42","author":"WJ Waldman","year":"1999","unstructured":"Waldman WJ, Knight DA, Blinder L, Shen J, Lurain NS, Miller DM, Sedmak DD, Williams JW, Chong AS (1999) Inhibition of cytomegalovirus in vitro and in vivo by the experimental immunosuppressive agent leflunomide. Intervirology 42(5\u20136):412\u2013418","journal-title":"Intervirology"},{"issue":"1","key":"1786_CR5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1600-6143.2005.01152.x","volume":"6","author":"AS Chong","year":"2006","unstructured":"Chong AS, Zeng H, Knight DA, Shen J, Meister GT, Williams JW, Waldman WJ (2006) Concurrent antiviral and immunosuppressive activities of leflunomide in vivo. Am J Transplant 6(1):69\u201375","journal-title":"Am J Transplant"},{"issue":"10","key":"1786_CR6","doi-asserted-by":"crossref","first-page":"4303","DOI":"10.1016\/j.transproceed.2005.10.116","volume":"37","author":"GT John","year":"2005","unstructured":"John GT, Manivannan J, Chandy S, Peter S, Fleming DH, Chandy SJ, Balakrishnan N, Krishnamurthy K, Kirubakaran MG, Jacob CK (2005) A prospective evaluation of leflunomide therapy for cytomegalovirus disease in renal transplant recipients. Transplant Proc 37(10):4303\u20134305","journal-title":"Transplant Proc"},{"issue":"4","key":"1786_CR7","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/MOT.0b013e32832dbc48","volume":"14","author":"N Leca","year":"2009","unstructured":"Leca N (2009) Leflunomide use in renal transplantation. Curr Opin Organ Transplant 14(4):370\u2013374","journal-title":"Curr Opin Organ Transplant"},{"issue":"5","key":"1786_CR8","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1136\/ard.2007.073221","volume":"67","author":"VS Sangle","year":"2008","unstructured":"Sangle VS, Sangle SR, D\u2019Cruz DP (2008) Leflunomide as a remission-maintaining therapy in difficult-to-treat dermatomyositis. Ann Rheum Dis 67(5):723","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1786_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2004.03.007","volume":"65","author":"DL Evers","year":"2005","unstructured":"Evers DL, Wang X, Huong SM, Andreoni KA, Huang ES (2005) Inhibition of human cytomegalovirus signaling, replication by the immunosuppressant FK778. Antiviral Res 65(1):1\u201312","journal-title":"Antiviral Res"},{"issue":"4","key":"1786_CR10","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/QCO.0b013e328307c7b4","volume":"21","author":"RK Avery","year":"2008","unstructured":"Avery RK (2008) Update in management of ganciclovir-resistant cytomegalovirus infection. Curr Opin Infect Dis 21(4):433\u2013437","journal-title":"Curr Opin Infect Dis"},{"issue":"1","key":"1786_CR11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1399-3046.2009.01183.x","volume":"14","author":"CE Araya","year":"2010","unstructured":"Araya CE, Garin EH, Neiberger RE, Dharnidharka VR (2010) Leflunomide therapy for BK virus allograft nephropathy in pediatric, young adult kidney transplant recipients. Pediatr Transplant 14(1):145\u2013150","journal-title":"Pediatr Transplant"},{"issue":"6","key":"1786_CR12","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1016\/j.transproceed.2009.06.099","volume":"41","author":"S Teschner","year":"2009","unstructured":"Teschner S, Gerke P, Geyer M, Wilpert J, Krumme B, Benzing T, Walz G (2009) Leflunomide therapy for polyomavirus-induced allograft nephropathy: efficient BK virus elimination without increased risk of rejection. Transplant Proc 41(6):2533\u20132538","journal-title":"Transplant Proc"},{"issue":"3","key":"1786_CR13","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1055\/s-2006-933412","volume":"218","author":"K Ehlert","year":"2006","unstructured":"Ehlert K, Groll AH, Kuehn J, Vormoor J (2006) Treatment of refractory CMV-infection following hematopoietic stem cell transplantation with the combination of foscarnet, leflunomide. Klin Padiatr 218(3):180\u2013184","journal-title":"Klin Padiatr"},{"issue":"1","key":"1786_CR14","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1399-3062.2006.00170.x","volume":"9","author":"M Battiwalla","year":"2007","unstructured":"Battiwalla M, Paplham P, Almyroudis NG, McCarthy A, Abdelhalim A, Elefante A, Smith P, Becker J, McCarthy PL, Segal BH (2007) Leflunomide failure to control recurrent cytomegalovirus infection in the setting of renal failure after allogeneic stem cell transplantation. Transpl Infect Dis 9(1):28\u201332","journal-title":"Transpl Infect Dis"},{"key":"1786_CR15","doi-asserted-by":"crossref","unstructured":"John GT, Manivannan J, Chandy S, Peter S, Jacob CK (2004) Leflunomide therapy for cytomegalovirus disease in renal allograft recepients. Transplantation. 15; 77(9):1460\u20131","DOI":"10.1097\/01.TP.0000122185.64004.89"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-010-1786-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-010-1786-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-010-1786-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T22:42:29Z","timestamp":1559947349000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-010-1786-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,18]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["1786"],"URL":"https:\/\/doi.org\/10.1007\/s00296-010-1786-6","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,18]]}}}